Related Experiment Videos
Chemotherapy drug resistance--a panel discussion
W L McGuire1, A Fojo, J H Goldie
1University of Texas Health Science Center, San Antonio.
Breast Cancer Research and Treatment
|November 1, 1987
Summary
Understanding tumor drug resistance is advancing rapidly. Research, including studies on P-glycoprotein, explains how cancer cells resist therapies, informing clinical applications.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Tumor drug resistance is a significant challenge in cancer therapy.
- Recent advancements offer new insights into the mechanisms of resistance.
- Experimental models have been crucial in understanding cellular resistance.
Purpose of the Study:
- To provide an overview of current understanding of tumor drug resistance.
- To examine the clinical relevance of proposed resistance mechanisms.
- To discuss findings from experimental models and theoretical viewpoints.
Main Methods:
- Review of theoretical, experimental, and clinical data on drug resistance.
- Focus on experimental models, particularly those involving P-glycoprotein.
- Panel discussion to synthesize and examine findings.
Main Results:
- Significant progress has been made in understanding why tumors develop drug resistance.
- Experimental models, especially those related to P-glycoprotein, have elucidated resistance mechanisms in cultured cells.
- Theoretical and clinical data support these findings.
Conclusions:
- An understanding of tumor drug resistance is becoming increasingly clear.
- The clinical relevance of various resistance mechanisms is under active examination.
- This field is rapidly evolving, offering hope for improved cancer treatments.